US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct ... and independent Bernie Sanders – have sent letters to the CEOs of the two pharma groups expressing the concern ...

Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...

WASHINGTON, DC - DECEMBER 20: Sen. Josh Hawley (R-MO) (L) and Sen. Bernie Sanders (I-VT) head for ... [+] the Senate Chamber for a procedural vote on the bipartisan federal omnibus spending ...

Sen. Bernie Sanders (I-Vt.) said Wednesday some of the bold steps that billionaire tech entrepreneur Elon Musk has taken to tackle waste in the federal government are “illegal.” “Nothing ...

Eli Lilly (NYSE:LLY) is setting the stage for a strong 2025, with its fourth-quarter results and forward guidance reflecting solid momentum. The company's adjusted earnings per share are expected ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 116 trades. If we consider the specifics of each ...

Eli Lilly expects 2024 revenue to be $45 billion, with Mounjaro and Zepbound sales contributing significantly. The company aims to increase Zepbound’s market share, competing with Novo Nordisk ...

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast Eli Lilly ...

Eli Lilly exceeded analyst forecasts for both sales and earnings in Q4 2024. As has been true for a while, sales of GLP-1 drugs Mounjaro and Zepbound drove both sales and earnings growth.

Bernie Sanders of Vermont and Sen. Josh Hawley of Missouri would curb credit-card annual percentage rates, or APRs, at 10% for five years. The interest rates that card issuers charge customers ...

Eli Lilly Mounjaro Zepbound GLP-1 Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same ...